JBPOS0101

DB16034InvestigationalSmall molecule

JBPOS0101 is under investigation in clinical trial NCT03976076 (A Study of Orally Administered JBPOS0101 in Refractory Infantile Spasms Patients).

Chemical structure of JBPOS0101
Formula / weight
C10H12ClNO3 · 229.66 g/mol (avg)
Code names
JBPOS-0101

Resolves to

Compound
UNIID7NM51C3GUCAS1353949-71-9ChEMBLCHEMBL4594413
Structure
InChIKeyTZOWVYPYWJLZTK-IMTBSYHQSA-NSMILESC[C@H](OC(N)=O)[C@@H](O)C1=CC=CC=C1Cl

What you can answer from here — as of July 16, 2026

1Clinical trialPhase, status and sponsor resolved per trial
Sign in
2+ReferencesStructured and connected to the statements they support
Sign in

Which companies are running trials of JBPOS0101, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In